Tag Archives: biotechnology law

Stem Cell Patents Webinar and BIO Int’l Convention Symposium

Posted on April 19, 2010 by Warren Woessner

Patent Claims Coverage Webinar: Stem Cell Industry – Osiris Therapeutics – Amgen’s EPO – Wed., April 28, 12:00PM – 12:50PM CDT Sunlight Research™ invites you to attend a Stem Cell Industry Patent Claims Coverage webinar presented by Robin A. Chadwick, … Continue reading →

Posted in Conferences and Classes, Stem Cells/Cloning | Tagged AUTM, bio, biotechnology, biotechnology law, intellectual property, stem cells, Sunlight Research, Warren Woessner | Leave a comment

The Return Of The Magnificent Prosecution Specialists Or Just More “QA”?

Posted on April 15, 2010 by Warren Woessner

The USPTO recently announced the creation of an ombudsman program to resolve applicant/examiner logjams in all of the Tech Centers. This is a move that the Office (and practitioners) have needed badly for a number of years, ever since the … Continue reading →

Posted in USPTO Practice and Policy | Tagged biotechnology law, intellectual property, ip, Patent Law, USPTO, Warren Woessner | Leave a comment

Is The “Golden Rule” Of Biological Drugs At Hand?

Posted on April 13, 2010 by Warren Woessner

I just finished speaking on IP issues involving biomarkers at a Q1 Conference in the Bay Area. Before the conference started, I spoke to the head patent counsel of a well-known bio/pharma company. He said, to my initial shock, that … Continue reading →

Posted in Organization/Business News | Tagged biotechnology law, biotechnology news, intellectual property, ip, Patent Law, patents, Warren Woessner | Leave a comment

Patenting Genes – The Conversation Myriad Needs To Start

Posted on April 5, 2010 by Warren Woessner

I watched “60 Minutes” last night, during which Kevin Noonan got about 30 seconds to justify “patenting genes” and the Myriad BRAC1-2 assays. He did as well as could be done, speaking about the good the patent system does in … Continue reading →